Activated NAD+ biosynthesis pathway induces olaparib resistance in BRCA1 knockout pancreatic cancer cells. Sasaki Y, Inouchi T, Nakatsuka R, Inoue A, et al. PLoS One 2024;19:e0302130.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sasaki Y, Inouchi T, Nakatsuka R, Inoue A, et al. Activated NAD+ biosynthesis pathway induces olaparib resistance in BRCA1 knockout pancreatic cancer cells. PLoS One 2024;19:e0302130.
PMID: 38625917